Future studies should incorporate imaging data, inflammatory biomarkers (e.g., CRP, IL-6), or metabolic pathways (e.g., insulin resistance, oxidative stress) to investigate potential mechanisms through which WWI may influence PRISm. The gene discussed is IL6; the disease is Insulin resistance.